Advertisement

Topics

Teva's tardive dyskinesia drug approved by FDA

04:56 EDT 31 Aug 2017 | SmartBrief

The FDA approved Teva Pharmaceutical Industries' Austedo, or deutetrabenazine, for use in adult patients with tardive dyskine -More

Original Article: Teva's tardive dyskinesia drug approved by FDA

NEXT ARTICLE

More From BioPortfolio on "Teva's tardive dyskinesia drug approved by FDA"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...